Åke Lernmark
21 – 30 of 842
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
- Contribution to journal › Article
-
Mark
Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19
- Contribution to journal › Article
-
Mark
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)
- Contribution to journal › Article
-
Mark
Joint modeling of multistate and nonparametric multivariate longitudinal data
- Contribution to journal › Article
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
- Contribution to journal › Article
-
Mark
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)
- Contribution to journal › Article
-
Mark
Autoimmune Type 1 Diabetes
(2024) p.203-215
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients
- Contribution to journal › Article
-
Mark
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
- Contribution to journal › Article
